Overview

Extension Study Investigating the Long-Term Safety and Tolerability of Repeat Doses of FE200486 in Prostate Cancer Patients

Status:
Terminated
Trial end date:
2006-03-01
Target enrollment:
Participant gender:
Summary
An Open-Label, Multi-Center, Extension Study Investigating the Long-Term Safety and Tolerability of Repeat Doses of FE200486 in Prostate Cancer Patients
Phase:
Phase 2
Details
Lead Sponsor:
Ferring Pharmaceuticals